Opinion|Videos|January 16, 2024

Treatment Approaches for Resectable Stage-III NSCLC in the Adjuvant Setting

Vinay Raja, MD, explores the crucial role of adjuvant immunotherapy in resectable stage III NSCLC, providing insights into patient selection criteria, considerations for choosing among available treatment options, and the impact of recent trial data updates on informing treatment decisions in this evolving therapeutic landscape.


Latest CME